{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:54:01Z","timestamp":1791071641459,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2145,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ijid.2006.09.010","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T15:06:10Z","timestamp":1169737570000},"page":"394-401","source":"Crossref","is-referenced-by-count":82,"title":["Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens"],"prefix":"10.1016","volume":"11","author":[{"given":"Ar\u00edstides Aguilar","family":"Betancourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A. Gonz\u00e1lez","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. Cinza","family":"Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Cabrera","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V\u00e9liz","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R. Moreno","family":"Aureoles-Rosell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Alem\u00e1n","family":"Zald\u00edvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Alonso","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Figueroa","family":"Baile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A. D\u00edas","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Olivera","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Correa","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Lobaina-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Delahanty","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I. Juvier","family":"Madrazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I. Alonso","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Lago","family":"Ba\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Puble","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. David","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E. Soto","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V. P\u00e9rez","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E. Pe\u00f1a","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Acosta","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J. Cerna","family":"Guanche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Mila","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S\u00e1nchez","family":"Betancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Hardy","family":"Rando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E. Guill\u00e9n","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.L. Muzio","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C. Aguilar","family":"Rubido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2006.09.010_bib1","first-page":"549","article-title":"Hepatitis B vaccination\u2014United States, 1982\u20132002","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2006.09.010_bib2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B virus infection","volume":"337","author":"Lee","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2006.09.010_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1473-3099(01)00118-9","article-title":"Treatment of chronic hepatitis B","volume":"1","author":"Yuen","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2006.09.010_bib4","series-title":"Viral hepatitis and liver disease","first-page":"532","article-title":"Overview on the epidemiology of hepatocellular carcinoma","author":"Beasley","year":"1991"},{"key":"10.1016\/j.ijid.2006.09.010_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s15010-003-3187-1","article-title":"Specific hepatitis B vaccine therapy in inactive HBsAg carriers: a randomized controlled trial","volume":"31","author":"Yalcin","year":"2003","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2006.09.010_bib6","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1128\/JVI.76.17.8609-8620.2002","article-title":"Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections","volume":"76","author":"Kakimi","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2006.09.010_bib7","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/S1386-6532(05)80019-8","article-title":"Therapeutic vaccination against chronic hepatitis B infection","volume":"34","author":"Michel","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijid.2006.09.010_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20011723","article-title":"Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection","volume":"195","author":"Reignat","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijid.2006.09.010_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/314828","article-title":"Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens","volume":"180","author":"Couillin","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2006.09.010_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2893.2004.00497.x","article-title":"Selective functional deficit in dendritic cell\u2014T cell interaction is a crucial mechanism in chronic hepatitis B virus infection","volume":"11","author":"Zheng","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2006.09.010_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2567.2003.01699.x","article-title":"Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape","volume":"109","author":"Beckebaum","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.ijid.2006.09.010_bib12","first-page":"206","article-title":"Clinical research on the treatment effect of autologous dendritic cell vaccine on the patients with chronic hepatitis B","volume":"11","author":"Li","year":"2003","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.ijid.2006.09.010_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1096-9071(200008)61:4<433::AID-JMV4>3.0.CO;2-5","article-title":"Dynamic study of HBsAg and HBeAg in saliva samples from patients with hepatitis B infection: diagnostic and epidemiological significance","volume":"61","author":"Zhevachevsky","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2006.09.010_bib14","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/S0264-410X(03)00268-8","article-title":"Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies","volume":"21","author":"Smith","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2006.09.010_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2003.08.120","article-title":"HCV core protein modulates the immune response against the HBV surface antigen in mice","volume":"310","author":"Aguilar","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijid.2006.09.010_bib16","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/S0264-410X(02)00191-3","article-title":"Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses","volume":"20","author":"Debin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2006.09.010_bib17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0264-410X(00)00348-0","article-title":"Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant","volume":"19","author":"Isaka","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2006.09.010_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.vaccine.2003.07.014","article-title":"Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection","volume":"22","author":"Chen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2006.09.010_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004836-200310000-00012","article-title":"The lack of effect of therapeutic vaccination with a pre-S2\/S HBV vaccine in the immune tolerant phase of chronic HBV infection","volume":"37","author":"Yalcin","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ijid.2006.09.010_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jmv.10509","article-title":"Cytokine-dependent antiviral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection","volume":"71","author":"Ren","year":"2003","journal-title":"J Med Virol"},{"issue":"Suppl 4","key":"10.1016\/j.ijid.2006.09.010_bib21","doi-asserted-by":"crossref","first-page":"A83","DOI":"10.1016\/S0264-410X(02)00393-6","article-title":"Towards immunotherapy for chronic hepatitis B virus infections","volume":"20","author":"Michel","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2006.09.010_bib22","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1128\/JVI.71.5.3365-3374.1997","article-title":"Characterization of CD8+ cytotoxic response after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B core and e antigens","volume":"71","author":"Townsend","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2006.09.010_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0161-5890(01)00081-5","article-title":"Peptide vaccines against hepatitis B virus: from animal model to human studies","volume":"38","author":"Engler","year":"2001","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ijid.2006.09.010_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.510300208","article-title":"A pilot study of CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group","volume":"30","author":"Heathcote","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2006.09.010_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.0818-9641.2004.01278.x","article-title":"Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen","volume":"82","author":"Aguilar","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.ijid.2006.09.010_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/000348940311200313","article-title":"Feasibility of aerosol vaccination in humans","volume":"112","author":"Roth","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ijid.2006.09.010_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.14.1.275","article-title":"Antigen sampling across epithelial barriers and induction of mucosal immune responses","volume":"14","author":"Neutra","year":"1996","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.ijid.2006.09.010_bib28","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1128\/JVI.67.4.2376-2380.1993","article-title":"Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein","volume":"67","author":"Bertoletti","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2006.09.010_bib29","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2006.09.010_bib30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.510260435","article-title":"Molecular features of the hepatitis B virus nucleocapsid T-cell epitopes 18-27: interaction with HLA and T-cell receptor","volume":"26","author":"Bertoletti","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2006.09.010_bib31","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/1521-4141(200107)31:7<2071::AID-IMMU2071>3.0.CO;2-D","article-title":"Induction of strong hepatitis B virus specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection","volume":"31","author":"Bocher","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijid.2006.09.010_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/JVI.66.1.106-114.1992","article-title":"The position of heterologous epitope inserted in hepatitis B virus core particles determines their immunogenicity","volume":"66","author":"Schodel","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2006.09.010_bib33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1099\/0022-1317-71-5-1109","article-title":"Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria","volume":"71","author":"Clarke","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ijid.2006.09.010_bib34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0006-291X(02)02897-8","article-title":"Mucosal immunogenicity of the hepatitis B core antigen","volume":"300","author":"Lobaina","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijid.2006.09.010_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molimm.2004.09.005","article-title":"Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen","volume":"42","author":"Lobaina","year":"2005","journal-title":"Mol Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2006.09.010_bib36","first-page":"S258","article-title":"Comparative study of the immunogenicity and immunoenhancing effects of two hepatitis B core antigen variants in mice by nasal administration","volume":"24","author":"Lobaina","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2006.09.010_bib37","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ijid.2006.09.010_bib38","first-page":"143","article-title":"Determinaci\u00f3n del potencial irritante de un candidato vacunal nasal que combina al ant\u00edgeno de superficie del virus de la hepatitis B con el ant\u00edgeno de la nucleoc\u00e1psida","volume":"21","author":"Porras","year":"2004","journal-title":"Biotecnolog\u00eda Aplicada"},{"key":"10.1016\/j.ijid.2006.09.010_bib39","first-page":"138","article-title":"Purificaci\u00f3n del ant\u00edgeno recombinante del core de la hepatitis B: y su uso potencial en el diagn\u00f3stico de la infecci\u00f3n con el virus de la hepatitis B","volume":"19","author":"Palenzuela","year":"2002","journal-title":"Biotecnolog\u00eda Aplicada"},{"key":"10.1016\/j.ijid.2006.09.010_bib40","unstructured":"Anti-HBs UMELISA. Code UM 2023. Immunoassay Center. February 5, 2002. Available at: http:\/\/www.tecnosuma.com\/Informacion\/Inserts\/LI-2023-E-022002.pdf (accessed September 2006)."},{"key":"10.1016\/j.ijid.2006.09.010_bib41","unstructured":"Anti-HBc UMELISA. Code UM 2029. Immunoassay Center. October 25, 2000. Available at: http:\/\/www.tecnosuma.com\/Informacion\/Inserts\/LI-2029-E-102000.pdf (accessed September 2006)."},{"key":"10.1016\/j.ijid.2006.09.010_bib42","first-page":"313","article-title":"Recommendations for protection against viral hepatitis","volume":"34","author":"Centers for Disease Control and Prevention (CDC)","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2006.09.010_bib43","first-page":"353","article-title":"Update on hepatitis B prevention","volume":"36","author":"Centers for Disease Control and Prevention (CDC)","year":"1987","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2006.09.010_bib44","first-page":"27","article-title":"Nasal flu vaccine approved","volume":"37","author":"Meadows","year":"2003","journal-title":"FDA Consum"},{"key":"10.1016\/j.ijid.2006.09.010_bib45","first-page":"169","article-title":"Summary of clinical findings on Engerix-B, a genetically engineered yeast-driven hepatitis B vaccine","volume":"63","author":"Andre","year":"1987","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijid.2006.09.010_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/160.5.766","article-title":"Vaccination against hepatitis B: comparison of three different vaccination schedules","volume":"160","author":"Jilg","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2006.09.010_bib47","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1542\/peds.107.4.626","article-title":"A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunological memory","volume":"107","author":"Cassidy","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2006.09.010_bib48","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0264-410X(97)00064-9","article-title":"A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin","volume":"15","author":"Berstad","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2006.09.010_bib49","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00002512-199608050-00006","article-title":"Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis","volume":"8","author":"Plosker","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ijid.2006.09.010_bib50","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1001\/jama.1985.03360220053027","article-title":"Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine","volume":"254","author":"Weber","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2006.09.010_bib51","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/infdis\/149.6.1019","article-title":"Hepatitis B vaccination in the elderly","volume":"149","author":"Denis","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2006.09.010_bib52","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/oxfordjournals.aje.a114061","article-title":"The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions","volume":"121","author":"Heyward","year":"1985","journal-title":"Am J Epidemiol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971206001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971206001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T14:28:22Z","timestamp":1683728902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971206001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1201971206001925"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2006.09.010","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}